In a $4.8 billion deal, Swiss life sciences giant Roche has agreed to acquire Spark Therapeutics, a University City-based developer of gene therapy treatment for genetic ailments.
{iframe}https://technical.ly/philly/2019/02/25/spark-therapeutics-acquired-roche-bill-marrazzo-university-city-science-center-gene-therapy/?utm_campaign=Philly%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=70223839&_hsenc=p2ANqtz-_ntNgD5do_hTigKn9_1fifyhhyL3k1Raz4cNUe56KS903wUJLAWASJqO7W4wYrff46LXSooQNNZz26AajvK_eQoRT4UA&_hsmi=70223839{/iframe}